RNA, U6 small nuclear 32, pseudogene (RNU6-32P)

RNU6-32P is a **pseudogene** derived from the U6 small nuclear RNA (snRNA) family. U6 snRNA is a highly conserved non-coding RNA that serves as a critical structural and functional core of the spliceosome, enabling the excision of introns from precursor mRNA during nuclear RNA processing in eukaryotes[5][1][3]. However, RNU6-32P does not produce a functional RNA product; it is a non-coding DNA sequence resulting from duplication or retrotransposition events but rendered inactive by mutation or lack of regulatory elements[1][7]. Unlike canonical U6 snRNA genes, which are active and essential for gene expression regulation via splicing, RNU6-32P’s only significance is as a genomic marker of historical evolution and gene family expansion; not as a pharmacological, clinical, or functional target. Pseudogenes like RNU6-32P may occasionally be transcribed, but there is no evidence for a biological function, disease association, or relevance as a drug target in medical or therapeutic contexts[1][5][3]. Summary of key distinctions: - **RNU6-32P is not a receptor, enzyme, or functional transcription factor.** - **It is a transcriptionally inactive pseudogene; confusion arises if it is classified as a therapeutic target.** - **Relevant molecular classification is “Other”— specifically “pseudogene” or “non-coding RNA pseudogene.”**

Other names

RNU6-32RNU6-32P

None. RNU6-32P is not a functional drug target.